menu
    • menu

    Company profile for MorphoSys

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    MorphoSys developed HuCAL, the most successful antibody library technology in the pharmaceutical industry. By successfully applying this and other patented technologies, MorphoSys has become a leader in the field of therapeutic antibodies, one of the fastest-growing drug classes in human healthcare. Together with its pharmaceutical partners, MorphoSys has built a therapeutic pipeline of more than 100 human antibody drug candid...
    MorphoSys developed HuCAL, the most successful antibody library technology in the pharmaceutical industry. By successfully applying this and other patented technologies, MorphoSys has become a leader in the field of therapeutic antibodies, one of the fastest-growing drug classes in human healthcare. Together with its pharmaceutical partners, MorphoSys has built a therapeutic pipeline of more than 100 human antibody drug candidates and other biologics for the treatment of cancer, rheumatoid arthritis, and Alzheimer’s disease, to name just a few.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    MorphoSysGermany Flag
    Country
    Country
    Germany
    Address
    Address
    Semmelweisstr. 7 82152 Planegg.
    Telephone
    Telephone
    +49 89 899 27-0
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.morphosys.com/de
    Linkedin
    Linkedin
    https://www.linkedin.com/company/morphosys-ag/?originalSubdomain=in
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/morphosys

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Novartis to close 2 MorphoSys sites, lay off 330 staffers
    Novartis to close 2 MorphoSys sites, lay off 330 staffers

    19 Dec 2024

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/novartis-shutter-2-morphosys-sites-lay-330-staffers-post-buyout-consolidation

    FIERCE PHARMA
    19 Dec 2024
    Share Share
    PharmaEssentia nabs MorphoSys alum for CCO role
    PharmaEssentia nabs MorphoSys alum for CCO role

    06 Dec 2024

    // FIERCE PHARMA

    https://www.fiercepharma.com/marketing/pharmaessentia-nabs-morphosys-gm-horvat-lead-its-commercial-team

    FIERCE PHARMA
    06 Dec 2024
    Share Share
    Novartis' $2.9B MorphoSys bet stumbles as safety delays filing
    Novartis' $2.9B MorphoSys bet stumbles as safety delays filing

    30 Oct 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/novartis-29b-morphosys-bet-stumbles-safety-signal-delays-filing-years

    FIERCE BIOTECH
    30 Oct 2024
    Share Share
    MorphoSys Announces Voluntary Delisting from the Nasdaq Global Market
    MorphoSys Announces Voluntary Delisting from the Nasdaq Global Market

    12 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240712469608/en

    BUSINESSWIRE
    12 Jul 2024
    Share Share
    MorphoSys And Novartis Plan Merger Squeeze-Out Of Minority Shareholders
    MorphoSys And Novartis Plan Merger Squeeze-Out Of Minority Shareholders

    20 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240619218783/en

    BUSINESSWIRE
    20 Jun 2024
    Share Share
    MorphoSys to Delist from Frankfurt Stock Exchange Following Novartis Acquisition
    MorphoSys to Delist from Frankfurt Stock Exchange Following Novartis Acquisition

    20 Jun 2024

    // CONTRACT PHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2024-06-20/morphosys-to-delist-from-frankfurt-stock-exchange-nasdaq-following-novartis-acquisition/9769

    CONTRACT PHARMA
    20 Jun 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search